Dividends & Buybacks ·
Fractyl Health effects one-for-twelve reverse stock split effective October 2
GUTSFractyl Health, Inc.
Fractyl Health, Inc. filed a Certificate of Amendment to its Amended and Restated Certificate of Incorporation with the Delaware Secretary of State on September 30, 2026, to effect a one-for-twelve (1-for-12) reverse stock split of its outstanding common stock. The amendment was approved by stockholders at a Special Meeting held on September 24, 2026, and subsequently authorized by the board of directors on the same date. The reverse split will become effective at 5:00 p.m. Eastern Time on October 2, 2026. Under this action, every twelve shares of common stock will be combined into one share without a change in par value. Proportionate adjustments will apply to outstanding stock options, restricted stock units, and warrants, while fractional shares will be cashed out. Trading on the Nasdaq Global Market is scheduled to resume on a split-adjusted basis on October 5, 2026. Fractyl Health operates in the biotechnology industry, focusing on developing therapies for metabolic diseases.